Covered Connecticut – Origins, Goals, Opportunities, and Concerns

Read the brief Covered Connecticut is a new program to cover uninsured state residents with no-cost health insurance coverage through Access Health CT, Connecticut’s health insurance exchange. The program leverages federal subsidies, some of which are temporary, and an anticipated Medicaid waiver to offer state residents combined with state funds. Some services, missing from exchange…

Read More

CTNJ OP-ED | Congress Wants to Lower Drug Prices to Fund Important Priorities

Economists argue that rising healthcare costs crowd out resources for other societal priorities such as education, infrastructure, climate change, and housing. It makes sense in theory but, until lately, it seemed a bit abstract. But right now, Congress and the administration are making the point in very real terms. Policymakers want to make big investments…

Read More

CTNJ: Insulin – Once a Gift, Now Serving Greed

Today is the hundredth anniversary of the discovery of insulin. Diabetes affects about 367,000 adults in Connecticut and that number is rising. Before the 1920s, a diabetes diagnosis was a death sentence. The discovery of insulin allowed people with diabetes to live their lives. Until the 1970s insulin was affordable, but it’s now so costly…

Read More

CTNJ: CT needs to focus on real health reform

Connecticut insurance premiums were the sixth highest among states for both individual and family coverage in 2019. Making healthcare more affordable was the drumbeat from voters last year. But CT policymakers have responded with weak options that kick the can down the road. Controlling the drivers of health costs is advanced placement politics. Powerful industries…

Read More

OP-ED | Controversial New Alzheimer’s Drug Could Break the Bank

Alzheimer’s disease affects six million Americans, stealing memories years before it takes lives. Aduhelm, the first drug intended to treat the Alzheimer’s disease process rather than symptoms, was highly anticipated by patients and families. But it has disappointed on many levels. It isn’t clear that it actually helps patients and troubling side effects are common.…

Read More

BOOK CLUB — The Right Price: A Value-Based Prescription for Drug Costs

For your summer reading. The Right Price: A Value-Based Prescription for Drug Costs offers the best explanation I’ve found of how drug costs are set, and how they should be. Using real-life patient stories, the authors give a balanced and comprehensive look at fair and reasonable pricing for a product that epitomizes market failure. The…

Read More

ANALYSIS | Who In Health Care Made Money on COVID?

Many COVID heroes who put their lives at risk or died caring for others. We all owe healthcare providers, scientists, public health professionals, and other frontline workers a huge debt of gratitude. But the healthcare industries did just fine. Four of the ten companies that profited most during the pandemic are in healthcare. Read more

Read More

NPR’s Frontline features Waterbury Hospital and private equity impact on hospitals

The latest NPR/Frontline investigation focuses on very unequal resources at US hospitals due to market forces and unequal government support. The second half of the documentary focuses on the impact of private equity buying safety net hospitals, which has doubled in the last decade. An expert describes how private equity firms purchase under-valued hospitals, cut…

Read More

OP-ED | When Data Becomes An Excuse To Prevent Change

Data is important. The drumbeat for data-driven policymaking in health care isn’t wrong. Policy decisions that aren’t informed by independent, valid analysis can cause more harm than good. But it’s important to know when we have enough data so we can get to work. Read more

Read More

Connecticut healthcare employment COVID recovery stalls out

Download the report Like other Connecticut workers, healthcare employment was hit hard by the pandemic in March 2020, according to data from the CT Department of Labor. While the pandemic sharply increased demand in a few healthcare sectors to care for COVID patients, other sectors declined as people and providers delayed non-COVID care. That began…

Read More